-
Featured Authors
One-on-One Partnering
Archive
- May 2013 (1)
- April 2013 (4)
- March 2013 (3)
- February 2013 (1)
- January 2013 (1)
- October 2012 (2)
- September 2012 (1)
- August 2012 (3)
- June 2012 (4)
- May 2012 (4)
- April 2012 (2)
- March 2012 (2)
- February 2012 (1)
- December 2011 (2)
- October 2011 (3)
- September 2011 (2)
- August 2011 (1)
- July 2011 (1)
- June 2011 (4)
- May 2011 (5)
- April 2011 (4)
- March 2011 (2)
- December 2010 (1)
- September 2010 (1)
- April 2010 (5)
- March 2010 (6)
- February 2010 (1)
- January 2010 (2)
Category Archives: The One-on-One Compass
Start 2012 with BIO – in Osaka!
With BIO’s Fall events behind us, the team here quickly shifted focus to 2012! On January 31st, the BIO Asia International Conference will commence its ninth year! What’s something new about the conference? It’s moved! Originally, BIO Asia was hosted in Tokyo, but the event has relocated for the first time and will now be held in Osaka, Japan. We’re very excited about being in this city, which is Japan’s third largest, and is well-known Read More >
BIO Investor Forum Company Snapshot: Protagonist Therapeutics
In our final Investor Forum Company Snapshot, we’ve profiled one of the Discovery Companies who will be presenting at the event. Protagonist Therapeutics shares their take on funding challenges and upcoming priorities, plus interesting facts about their company. Don’t miss their presentation first thing Tuesday morning! Company Snapshot What are the short-term and long-term priorities for your company? Protagonist is a peptide therapeutics based technology platform company. Short term priority: Secure a second collaboration and Read More >
A What Would George Do? Tribute
For those of you who have been attending BIO events over the past few years, you’ve not only come to know the One-on-One Partnering System, but BIO staff as well. In particular, our Partnering Guru George MacDougall, – the very person our blog is named after! Recently, George accepted a position at another DC non-profit and is moving on from BIO. In honor of all his hard work, exceptional customer service, and contributions to the Read More >
BIO Investor Forum Company Snapshot: Immune Design
In the third installment of the Investor Forum Company Snapshots, hear from Immune Design Corp. The CEO of the company, Dr. Carlos Paya, will be presenting next week at the 10th Annual BIO Investor Forum on Tuesday afternoon. Company Snapshot What are the short-term and long-term priorities for your company? Short term: focus on validating in patients a product from each of our two novel technologies. We will be conducting testing of : 1) An Read More >
BIO Investor Forum Company Snapshot: Syndax Pharmaceuticals
Next up in our Company Snapshot segment for the BIO Investor Forum is another presenting company of the event. Hear from Joanna Horobin, President & CEO of Syndax Pharmaceuticals, Inc. Company Snapshot What are the short-term and long-term priorities for your company? Near-term we are focused on moving our lead product candidate, entinostat, in to a phase 3 clinical trial for post-menopausal women with estrogen receptor-positive (ER+) metastatic breast cancer (MBC). Long-term our goal is Read More >
